Real-world Effectiveness and Safety of Vedolizumab for the Treatment of Inflammatory Bowel Disease: The Scottish Vedolizumab Cohort

Plevris, N; Chuah, CS; Allen, RM; Arnott, ID; Brennan, PN; Chaudhary, S; Churchhouse, AMD; Din, S; Donoghue, E; Gaya, DR; Groome, M; Jafferbhoy, HM; Jenkinson, PW; Lam, WL; Lyons, M; Macdonald, JC; MacMaster, M; Mowat, C; Naismith, GD; Potts, LF; Saf

Plevris, N (reprint author), Western Gen Hosp, Edinburgh IBD Unit, Edinburgh EH4 2XU, Midlothian, Scotland.

JOURNAL OF CROHNS & COLITIS, 2019; 13 (9): 1111

Abstract

Background & Aims: Vedolizumab is an anti-a4b7 monoclonal antibody that is licensed for the treatment of moderate to severe Crohn's disease and ul......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索